Baker Tilly Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History
Baker Tilly Wealth Management, LLC
- $273 Million
- Q2 2025
A detailed history of Baker Tilly Wealth Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Baker Tilly Wealth Management, LLC holds 2,908 shares of VRTX stock, worth $1.13 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
2,908
Previous 2,988
2.68%
Holding current value
$1.13 Million
Previous $1.45 Million
10.64%
% of portfolio
0.47%
Previous 0.58%
Shares
16 transactions
Others Institutions Holding VRTX
# of Institutions
1,811Shares Held
239MCall Options Held
1.52MPut Options Held
1.01M-
Capital World Investors Los Angeles, CA28.7MShares$11.1 Billion1.94% of portfolio
-
Vanguard Group Inc Valley Forge, PA24MShares$9.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.26 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA16.1MShares$6.25 Billion1.5% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.57 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $99.5B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...